• 제목/요약/키워드: Radiation dosage

검색결과 168건 처리시간 0.024초

Anti-Cancer Effect of Ginsenoside F2 against Glioblastoma Multiforme in Xenograft Model in SD Rats

  • Shin, Ji-Yon;Lee, Jung-Min;Shin, Heon-Sub;Park, Sang-Yong;Yang, Jung-Eun;KimCho, So-Mi;Yi, Tae-Hoo
    • Journal of Ginseng Research
    • /
    • 제36권1호
    • /
    • pp.86-92
    • /
    • 2012
  • The glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults. Despite combination treatments of radiation and chemotherapy, the survival periods are very short. Therefore, this study was conducted to assess the potential of ginsenoside $F_2$ (F2) to treat GBM. In in vitro experiments with glioblastoma cells U373MG, F2 showed the cytotoxic effect with $IC_{50}$ of 50 ${\mu}g/mL$ through apoptosis, confirmed by DNA condensation and fragmentation. The cell population of cell cycle sub-G1 as indicative of apoptosis was also increased. In xenograft model in SD rats, F2 at dosage of 35 mg/kg weight was intravenously injected every two days. This reduced the tumor growth in magnetic resonance imaging images. The immunohistochemistry revealed that the anticancer activity might be mediated through inhibition of proliferation judged by Ki67 and apoptosis induced by activation of caspase-3 and -8. And the lowered expression of CD31 showed the reduction in blood vessel densities. The expression of matrix metalloproteinase-9 for invasion of cancer was also inhibited. The cell populations with cancer stem cell markers of CD133 and nestin were reduced. The results of this study suggested that F2 could be a new potential chemotherapeutic drug for GBM treatment by inhibiting the growth and invasion of cancer.

새 구조의 액정 엑스선 감지기 (A New X-Ray Image Sensor Utilizing a Liquid Crystal Panel)

  • 노봉규
    • 한국광학회지
    • /
    • 제19권4호
    • /
    • pp.249-254
    • /
    • 2008
  • 새 구조의 액정 엑스선 감지기를 만들었다. 이것은 액정판을 만들고 유리판을 얇게 식각한 다음, 그 유리판 위에 반사막과 광전도층을 연속하여 입힌 구조이다. 새 구조의 액정엑스선 감지기는 공정의 안정성, 대면적화, 감도 등에서 이미 상품화된 엑스선 감지기와도 충분히 경쟁할 수 있으며, 따라서 성공적으로 상용화 할 수 있음을 확인했다.

Novel stability indicating high-performance liquid chromatography method for the separation and simultaneous quantification of acalabrutinib and its impurities in pharmaceutical formulation

  • Venu Gopal Kamani;Sujatha M;Guna Bhushana Daddala
    • 분석과학
    • /
    • 제36권1호
    • /
    • pp.32-43
    • /
    • 2023
  • This study reports for the first time about a stability indicating RP-HPLC method for qualitative and quantitative determination of acalabrutinib in bulk and dosage form and in presence its impurities 1, 2 and 3. The chromatographic separation was carried on Zorbax XDB-C18 (250×4.6 mm; 5 µ id) as stationary phase, Phosphate buffer pH 6.4 and methanol 80:20 (v/v) as mobile phase at a flow rate of 1.0 mL/min, UV detection was carried at wavelength of 238 nm and the analysis was completed with a run time of 15 min. In these conditions the retention time of acalabrutinib and its impurities 1, 2 and 3 was observed to be 3.50, 4.83, 8.40 and 9.93 min respectively. The method was validated for system suitability, range of analysis, precision, specificity, stability and robustness. Spiked recovery at 50 %, 100 % and 150 % was carried for both standard and impurities and the acceptable % recovery of 98-102 was observed for acalabrutinib and both impurities studied and the % RSD in each spiked level was found to be less than 2. Stability tests were done through exposure of the analyte solution to five different stress conditions i.e expose to 1N hydrochloric acid, 1 N sodium hydroxide, 3 % peroxide, 80 ℃ temperature and UV radiation at 254 nm. In all the degradation condition, standard drug acalabrutinib was detected along with both the impurities studied and the degradation products were successfully separated. In the formulation analysis there is no other chromatographic detection of other impurities and formulation excipients. Hence the developed method was found to be suitable for the quantification of acalabrutinib and can separate and analyse impurities 1 and 2.

표적 알파 치료의 현황 및 유용성에 대한 임상적 고찰 (Clinical Review of the Current Status and Utility of Targeted Alpha Therapy)

  • 최상규
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제46권5호
    • /
    • pp.379-394
    • /
    • 2023
  • Targeted Alpha Therapy (TAT) is a new method of cancer treatment that protects normal tissues while selectively killing tumor cells using high cytotoxicity and short range of alpha particles, and target alpha therapy is a highly specific and effective cancer treatment strategy, and its potential has been proven through many clinical and experimental studies. This treatment method accurately delivers alpha particles by selecting specific molecules present in cancer tissue, which has an effective destruction and tumor suppression effect on cancer cells, and one of the main advantages of target alpha treatment is the physical properties of alpha particles. Alpha particles have a very high energy and short effective distance, interacting with target molecules in cancer tissues and having a fatal effect on cancer cells, which is known to cause DNA damage and cell death in cancer cells. TAT has shown positive results in preclinical and clinical studies for various types of cancers, especially those that resist or are unresponsive to existing treatments, but there are several challenges and limitations to overcome for successful clinical transition and application. These include the provision and production of suitable alpha radioisotopes, optimization of target vectors and delivery formulations, understanding and regulation of radiological effects, accurate dosage calculation and toxicity assessment. Future research should focus on developing new or improved isotopes, target vectors, transfer formulations, radiobiological models, combination strategies, imaging techniques, etc. for TAT. In addition, TAT has the potential to improve the quality of life and survival of cancer patients due to the possibility of a new treatment for overcoming cancer, and to this end, prospective research on more carcinomas and more diverse patient groups is needed.

Combination of red ginseng and velvet antler extracts prevents skin damage by enhancing the antioxidant defense system and inhibiting MAPK/AP-1/NF-κB and caspase signaling pathways in UVB-irradiated HaCaT keratinocytes and SKH-1 hairless mice

  • Van-Long Truong;Yeon-Ji Bae;Ji-Hong Bang;Woo-Sik Jeong
    • Journal of Ginseng Research
    • /
    • 제48권3호
    • /
    • pp.323-332
    • /
    • 2024
  • Background: Studies have reported that the combination of two or more therapeutic compounds at certain ratios has more noticeable pharmaceutical properties than single compounds and requires reduced dosage of each agent. Red ginseng and velvet antler have been extensively used in boosting immunity and physical strength and preventing diseases. Thus, this study was conducted to elucidate the skin-protective potentials of red ginseng extract (RGE) and velvet antler extract (VAE) alone or in combination on ultraviolet (UVB)-irradiated human keratinocytes and SKH-1 hairless mice. Methods: HaCaT cells were preincubated with RGE/VAE alone or in combination for 2 h before UVB (30 mJ/cm2) irradiation. SKH-1 mice were orally given RGE/VAE alone or in combination for 15 days before exposure to single dose of UVB (600 mJ/cm2). Treated cells and treated skin tissues were collected and subjected to subsequent experiments. Results: RGE/VAE pretreatment alone or in combination significantly prevented UVB-induced cell death, apoptosis, reactive oxygen species production, and DNA damage in keratinocytes and SKH-1 mouse skins by downregulating mitogen-activated protein kinases/activator protein 1/nuclear factor kappa B and caspase signaling pathways. These extracts also strengthened the antioxidant defense systems and skin barriers in UVB-irradiated HaCaT cells and SKH-1 mouse skins. Furthermore, RGE/VAE co-administration appeared to be more effective in preventing UVB-caused skin injury than these extracts used alone. Conclusion: Overall, these findings suggest that the consumption of RGE/VAE, especially in combination, offers a protective ability against UVB-caused skin injury by preventing inflammation and apoptosis and enhancing antioxidant capacity.

핵의학검사의 방사성의약품 소아투여량 공식 별 투여량 및 유효선량 비교 (Comparing of the Administered Activities and the Effective Dose of the Various Pediatric Dose Formulas of Nuclear Medicine)

  • 길종원
    • 한국융합학회논문지
    • /
    • 제8권8호
    • /
    • pp.147-154
    • /
    • 2017
  • 본 연구는 소아핵의학검사에 사용하는 다양한 소아투여량 공식의 투여량(MBq)과 유효선량(mSv)을 산출 비교하여 적정투여량의 기준을 위한 기초자료를 제공하고자 한다. 연구는 2가지 방사성의약품($^{99m}Tc$-MDP와 $^{99m}Tc$-Pertechnetate)의 성인투여량을 기준으로 5가지 소아투여량공식(Clark법, Area법, Webster법, Young법, Solomon(Fried)법) 간 투여량과 유효선량을 비교하였다. 소아투여량 산출에 기준이 되는 성인투여량은 정준기, 이명철 '핵의학'에 수록된 값을 사용하였으며, 유효선량 산출을 위한 방사성의약품의 방사능당 유효선량(mSv/MBq)은 ICRP 80과 UNSCEAR 2008 보고서에 수록된 값을 사용하였다. 연구결과 Young법이 산출량이 가장 적으며 다른 공식과의 차이는 최소 1.7배-최대 3.4배였다. $^{99m}Tc$-MDP의 공식 간 투여량 차이는 최대 309.9MBq, 유효선량은 3.76mSv, $^{99m}Tc$-Pertechnetate는 최대 154.9MBq, 유효선량은 5.50mSv였다. 소아투여량 공식 간 투여량뿐만 아니라 유효선량도 차이가 크기 때문에 의료방사선의 최적화를 위한 적정투여량 소아산출법이 개발되어야 한다.

디지털 방사선의학에서의 조사선량 설정과 인지에 대한 실태 - 대구 경북지역을 중심으로 - (A Study on the Exposure Parameter and the Patient Dose for Digital Radiography System in Dae Goo)

  • 조광호;강영한;김부순
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제31권2호
    • /
    • pp.177-182
    • /
    • 2008
  • 디지털 시스템이 가지는 장점인 영상판 검출기의 반응 범위(dynamic range)가 상당히 넓다는 것은 필름/증감지 시스템보다 더 높은 수준의 노광 관용도를 갖기에 재촬영이 줄어들고 영상관리에 효율적이지만, 조사조건의 설정범위가 상당히 넓어 필름/증감지 시스템의 엄격한 조사조건보다 더 많은 조사선량이 환자에게 노출 될 수도 있다. 본 연구는 디지털 시스템 하에서 일반촬영 시 방사선사 개인 별 조사선량에 대한 인식과 행위실태를 파악하여 환자피폭선량을 감소시킬 수 있는 방안을 마련하고, 방사선 선량관리의 중요성을 새로이 인식하고자 하였다. 디지털 시스템 하에서 근무 중인 방사선사의 조사조건 설정과 환자피폭선량 인지 실태를 파악해 본 결과 환자의 체형이나 상태, 촬영부위에 따라 최적의 조사선량을 적용하기 보다는 영상의 농도와 업무의 편의성에 따라 조사조건이 설정되고 있었다. 디지털 시스템이 도입되며 검출기의 반응 범위가 필름/스크린 시스템보다 넓어짐에 따라 조사조건 설정에 대해 관심이 소홀한 경향이 있었다. 따라서 디지털 방사선 시스템 하에서 환자 피폭선량의 감소를 위해 최적의 조사조건으로 영상을 얻어야 할 것이다. 또한 조사선량을 최소로 하고 환자 피폭선량을 줄이기 위해 업무 습관과 인식을 새로이 할 필요성이 있고, 지속적인 관심과 주기적인 교육 및 점검, 다양한 교육 기회제공 등이 필요하다고 본다.

  • PDF

DMBA 유도 햄스터 협낭암 발생과정에서 방사선 조사가 증식세포핵항원(PCNA)의 발현과 apoptosis 유발에 미치는 영향 (The Effect of Irradiation on the Expression of PCNA and Apoptosis Induction during the DMBA Induced Carcinogenesis in Hamster Buccal Pouch)

  • 전인성;허민석;최항문;이삼선;최순철
    • Imaging Science in Dentistry
    • /
    • 제30권3호
    • /
    • pp.207-216
    • /
    • 2000
  • Purpose : This study was carried out to investigate the effect of irradiation on the expression of proliferating cell nuclear antigen (PCNA) and apoptosis induction during the carcinogenesis in hamster buccal pouch. Materials and methods: Three months old Syrian golden hamsters were divided into control and 2 experimental groups. Hamsters in control group were left untreated on buccal pouchs. Twenty four hamsters were treated with 0.5% DMBA tri-weekly on the right buccal pouch. Forty eight hamsters were treated with 0.5% DMBA tri-weekly and irradiated with the dose of 5 Gy and 10 Gy at 6, 9, 12, 15 weeks after DMBA application. Resected buccal pouches were sectioned and examined for potential expression pattern of PCNA and apoptosis. Results : The PCNA index was increased with the stages of buccal pouch epithelium carcinogenesis except the hyperplasia stage in control group (p<0.05). The irradiation did not effect on the PCNA index in the dysplasia and the carcinoma in situ stage, but in the hyperplasia stage, the PCNA index was increased with 10 Gy radiation and decreased in the carcinoma stage (p<0.05). The apoptotic index was significantly decreased from the carcinoma in situ stage and the lowest in the carcinoma stage. The apoptotic index was significantly decreased in the hyperplasia and dysplasia stage with the 5 Gy irradiation and significantly increased only in the carcinoma stage with the 10 Gy irradiation (p<0.05). Conclusion: The PCNA and apoptotic index were varied according to the irradiation period and dosage in each carcinogenesis stage.

  • PDF

이동형 구내방사선촬영기와 벽걸이 구내방사선촬영기로 촬영한 치근단 방사선촬영에서 환자의 흡수선량과 유효선량 평가 (Absorbed and effective dose for periapical radiography using portable and wall type dental X-ray machines)

  • 한원정
    • 대한치과보철학회지
    • /
    • 제50권3호
    • /
    • pp.184-190
    • /
    • 2012
  • 연구 목적: 이 연구는 상악 전치부와 하악 구치부 치근단 방사선촬영시 이동형 구내방사선촬영기와 벽걸이 구내방사선촬영기로 촬영한 경우에서 환자의 방사선량을 알아보고자 하였다. 연구 재료 및 방법: 방사선량 측정은 선량 측정용 두경부 마네킨의 23부위에 열형광선량계 소자를 위치시키고 해당 치근단 방사선촬영을 하였다. 열형광선량계 판독기로 흡수선량을 구하였고 방사선 조사된 조직의 비율을 곱하여 방사선 가중선량을 구하였다. 국제방사선방호위원회에서 2007년에 공지한 조직 가중계수를 이용하여 각 방사선촬영의 유효선량을 구하였다. 결과: 환자의 흡수선량은 이동형 구내방사선촬영기로 촬영한 상악 전치부와 이동형 및 벽걸이 구내방사선촬영기로 촬영한 하악 구치부 치근단방사선촬영의 경우 하악체에서 가장 높았다. 유효선량은 상악 전치부 치근단 방사선촬영에서는 이동형 촬영기로 촬영한 경우 $4{\mu}Sv$, 벽걸이 촬영기로 촬영한 경우 $2{\mu}Sv$였고 우측 하악 구치부 치근단 방사선촬영에서는 각각 $6{\mu}Sv$, $2{\mu}Sv$였다. 결론: 벽걸이 구내방사선촬영기보다 이동형 구내방사선촬영기로 촬영한 치근단 방사선촬영에서의 유효선량이 더 많기 때문에 술자는 구내방사선촬영기에 따른 방사선 노출 정도를 충분히 인지하고 이를 사용하여야 한다.

양이온교환수지에 대한 Co(II), Ni(II), Cr(III), Fe(III) 이온의 흡착 특성 - 원자로 일차 냉각재 계통내 탈염 공정에의 적용 (Adsorption Characteristics of Co(II), Ni(II), Cr(III) and Fe(III) Ions onto Cation Exchange Resin - Application to the Demineralizing Process in a Primary Coolant System of PWR)

  • 강소영;이병태;이종운;문승현;김경웅
    • Journal of Radiation Protection and Research
    • /
    • 제27권1호
    • /
    • pp.27-35
    • /
    • 2002
  • 가압경수로 일차냉각수내 탈염공정의 효과적 운용을 위하여 Amberlite IRN-77 양이온 교환수지의 특성 및 Co(II), Ni(II), Cr(III), Fe(III) 이온의 흡착거동을 연구하였다. 용존 금속이온 농도가 약 $200\;mgL^{-1}$인 용액 100 mL에 대하여 이온교환수지 투입량은 약 0.6 g이 가장 적절하였으며, 이온교환 반응 속도 측정 결과 대부분의 흡착은 반응 1 시간 이내에 신속히 발생하였다. 수지에서의 양이온 교환은 Langmuir 흡착등온선을 잘 따르는 것으로 나타났으나, Fe(III)의 경우, 다른 금속과는 달리 쉽게 평형에 이르지 못하였으며 이는 공기와 오래 접촉한 결과 철산화물 또는 수산화물을 형성하며 용액 중으로부터 침전되기 때문인 것으로 관찰되었다. 전자가가 동일한 Co(II)와 Ni(II)가 동시에 포함된 모의 조제용액에 대하여 흡착실험을 한 결과, 각 이온은 거의 동일한 흡착거동을 보였다. 그러나 전자가가 큰 Cr(III)이 첨가된 경우, 이들은 기존에 수지에 흡착되어 있던 전자가가 낮은 금속들을 탈착시키고 대신 흡착하는 경향을 보였다. 따라서 이온교환수지를 이용한 효과적인 탈염 공정을 위해서는 용존 금속 상호간의 경쟁적 흡착관계의 규명이 필요한 것으로 여겨진다.